Results 101 to 110 of about 65,325 (216)

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Palivizumab for the Prophylaxis of Respiratory Syncytial Virus Disease: Expert Opinion and Recommendations for the Gulf Cooperation Council Region

Oman Medical Journal
Respiratory syncytial virus (RSV) infection poses a significant health threat to infants and young children. Considering the substantial burden in Gulf Cooperation Council (GCC) countries, prevention of RSV remains a major public health priority ...
Adel S. Alharbi, Abdul Rahman Alnemri, Ahmed Abushahin, Entesar Alhammadi, Huda Sulaiman Mohammed AlDhanhani, Laila Obaid , Mahmoud Saleh ElHalik, Mariam Kh Ayed   +7 more
doaj   +1 more source

Hemophagocytic Macrophages in the Peripheral Blood of a Critically Ill Patient With COVID‐19 and RSV Infection

American Journal of Hematology, Volume 101, Issue 5, Page 1070-1071, May 2026.
Ashik Zala, Ahmed Sadek, Ahmed Elsaid, Ketan C. Patel, Maximiliano Ramia De Cap, Barbara J. Bain   +5 more
wiley   +1 more source

Epidemiological Characteristics and Co‐Detection Patterns of Rhinovirus (A/B/C) and Influenza A Virus in a Regional Respiratory Cohort in Hunan, China

The Clinical Respiratory Journal, Volume 20, Issue 5, May 2026.
This study analyzed 386 rhinovirus infections (dominant Type A, 60.9%; high 73.1% coinfection rate) and Influenza A interactions. Rhinovirus A/B showed mutual exclusivity with Influenza A, while Type C had near‐random association, with temporal prevalence fluctuations observed. ABSTRACT Objective To characterize the epidemiological profile, coinfection
Feicheng Yang, Ping Bai, Jiaxuan Zhang, Juqi Peng, Qing Hu, Yanchun Li   +5 more
wiley   +1 more source

Effects of COVID-19 pandemic–associated reduction in respiratory infections on infantile asthma development

Journal of Allergy and Clinical Immunology: Global
Background: It is speculated that the coronavirus disease 2019 (COVID-19) pandemic–associated reduction in the prevalence of respiratory tract infections has influenced the incidence of asthma in young children. Objectives: We investigated an association
Chinami Kaiga, MD, Manabu Miyamoto, MD, PhD, Takashi Matsushita, MD, Yu Kuramochi, MD, Hiromi Tadaki, MD, PhD, Mayumi Enseki, MD, PhD, Kota Hirai, MD, PhD, Shigemi Yoshihara, MD, PhD, Hiroyuki Furuya, MD, PhD, Fumio Niimura, MD, PhD, Masahiko Kato, MD, PhD, Hiroyuki Mochizuki, MD, PhD   +11 more
doaj   +1 more source

Severe HCoV‐OC43 Pneumonia in a 25‐Year‐Old Woman Following Allogeneic Hematopoietic Stem Cell Transplantation

The Clinical Respiratory Journal, Volume 20, Issue 5, May 2026.
This case reports a 25‐year‐old allo‐HCT recipient with severe HCoV‐OC43 pneumonia who responded well to off‐label nirmatrelvir/ritonavir. It is the first such report that show the drug may benefit immunocompromised patients with this infection, though further studies are needed to confirm efficacy.
Mingzhou Zhang, Ting Tang, Mingxia Zheng, Menglin Luo, Zhi Xu, Guansong Wang   +5 more
wiley   +1 more source

Circulation of Influenza and Other Respiratory Viruses in Tunisia, 2022–2023 Season

Influenza and Other Respiratory Viruses, Volume 20, Issue 5, May 2026.
ABSTRACT Introduction Influenza sentinel surveillance has been ongoing in Tunisia since 1999. We describe the epidemiology of respiratory viruses during 2022–2023, the first season to include testing for other respiratory viruses, such as respiratory syncytial virus (RSV).
Bouslah Zoubeir, Bouguerra Hind, Dhaouadi Sonia, Abid Salma, Whitehouse Erin Rachel, El Ghord Hakim, Yazidi Rihab, Ben Mrad Nacef, Miraoui Amal, Bougharriou Ichrak, Ennouri Emna, Ben Slimen Najla, Guebsi Nour El Houda, Toumi Radhouane, Bouabid Leila, Ben Hamida Chokri, Merhabane Takoua, Boussarsar Mohamed, Ben Jemaa Mounir, Menif Khaled, Ben Khelil Jalila, Ben Alaya Nissaf, Ben Salah Afif, Laouini Dhafer, Zureick Kinda, Boutiba‐. Ben Boubaker Ilhem   +25 more
wiley   +1 more source

Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025

Influenza and Other Respiratory Viruses, Volume 20, Issue 5, May 2026.
ABSTRACT Background Human respiratory syncytial virus (HRSV) imposes a substantial burden in the United States. The use of whole‐genome sequencing (WGS) for public health surveillance of HRSV lags that for other viral pathogens. The objective of this study was to expand the scope and depth of WGS‐based surveillance of HRSV in Minnesota, USA.
Daniel Evans, Henry Kunerth, Erica Mumm, Matthew Plumb, Laura Bohnker‐Voels, Sarah Bistodeau, Scott A. Cunningham, Jordan Davis, Karen Martin, Kathryn Como‐Sabetti, Sarah Namugenyi, Xiong Wang, Ruth Lynfield, Anna Strain, Sara Vetter   +14 more
wiley   +1 more source

Respiratory Syncytial Virus Hospitalizations Among Adults in Thailand: A Nationwide Retrospective Observational Study (RSV‐HAT)

Influenza and Other Respiratory Viruses, Volume 20, Issue 5, May 2026.
ABSTRACT Background Respiratory syncytial virus (RSV) is a major cause of acute respiratory infection (ARI) in adults, especially older individuals, yet data on burden in Thailand are limited. This study aimed to describe clinical characteristics and mortality risk factors of RSV‐related hospitalizations in Thai adults.
Kanrutai Jarottammarat, Kanokkarn Pinyopornpanish, Chadakan Yan, Bussakorn Mahakkanukrauh, Otavio Cintra, Adriana Guzman‐Holst, Phichayut Phinyo, Wipa Reechaipichitkul   +7 more
wiley   +1 more source

Clinical and Postoperative Applications of Manuka Honey in Wound Healing: An Evidence‐Based Review

International Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT Chronic and postoperative wounds remain challenging to manage, with high risks of infection, delayed healing and increased costs. Manuka honey offers antibacterial, anti‐inflammatory, antioxidant and tissue‐regenerative properties through methylglyoxal, phenolic compounds, high sugar content and low pH.
Ayman N. Alhabsi, Abdullah Al Lawati, Lubna Al Hashmi, Fatema Al‐Isaii, Alwaleed Alghammari, Srijit Das, Sheikhan Al Hashmi   +6 more
wiley   +1 more source